Module structure (12–14 weeks, 3hr lecture + 3hr lab/week)
Collectors value MIDE-950 for three primary reasons: MIDE-950
The MIDE-950 operates through a specific mechanism of action, targeting a particular enzyme or receptor involved in various cellular processes. Research has shown that MIDE-950 acts as a potent inhibitor of the fatty acid amide hydrolase (FAAH) enzyme. FAAH is responsible for the hydrolysis of endocannabinoids, such as anandamide and N-pachidonic acid, which play crucial roles in regulating physiological processes, including pain, mood, and inflammation. Module structure (12–14 weeks, 3hr lecture + 3hr
| Risk | Description | Mitigation | |------|-------------|------------| | | A 950 nm BOX requires precise oxidation and CMP; non‑uniformity can cause device‑to‑device V th spread. | MIDE’s inline metrology (spectroscopic ellipsometry) and post‑process planarization have reduced BOX RMS variation to < 3 nm, improving yield to > 85 % for HV blocks. | | Design‑Complexity for Body‑Bias | Leveraging the thick BOX for adaptive bias needs careful modelling. | The Body‑Bias™ Manager provides ready‑to‑use tables; MIDE offers design‑for‑reliability (DfR) workshops. | | Competition from 3‑D Integration | Stacked‑die solutions could replace single‑die HV isolation. | MIDE‑950 can be back‑end‑of‑line (BEOL) stacked with other 28 nm FD‑SOI layers, enabling heterogeneous 3‑D while retaining thick BOX isolation. | | Cost Premium | 28 nm FD‑SOI with 950 nm BOX is ~ 20 % more expensive per wafer than bulk 28 nm. | The total‑system cost (fewer external components, higher reliability) often results in net savings for automotive & RF OEMs. | improving yield to >